Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methodological issues and new developments in the economic evaluation of vaccines.

Philippe Beutels1, Eddy Van Doorslaer, Pierre Van Damme

  • 1National Center for Immunisation Research and Surveillance, University of Sydney and Center for Health Economics Research and Evaluation, Australia.

Expert Review of Vaccines
|January 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing Hyperoxemia in Mechanically Ventilated Emergency Department Patients: A Before-and-After Study.

The Journal of emergency medicine·2026
Same author

Cost-Effective Threshold Price for Alternative Infant and Neonatal Rotavirus Vaccines: A Dual-Country Evaluation.

medRxiv : the preprint server for health sciences·2026
Same author

Estimating EQ-5D-5L quality-adjusted life year weights from GHQ-12 mental health data: a large sample exploration of four mapping methods.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Prevalence of hepatitis B surface antibodies and hepatitis B exposure in Belgium: results from a nationwide population-based serosurvey.

BMC infectious diseases·2026
Same author

Comparative analysis of the impact of chickenpox and herpes zoster vaccination in Belgium under two different exogenous boosting mechanisms.

PloS one·2026
Same author

Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same journal

Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic.

Expert review of vaccines·2026
Same journal

Narrative shielding and prebunking: a synergistic strategy against vaccine hesitancy in pediatrics.

Expert review of vaccines·2026
Same journal

Cost-effectiveness and public health impact of RSV immunization for all infants in Japan: a mixed strategy with nirsevimab and RSVpreF.

Expert review of vaccines·2026
Same journal

Post-pandemic impact on the epidemiology of invasive pneumococcal disease: consensus statement from the Latin American Society of Pediatric Infectious Diseases (SLIPE).

Expert review of vaccines·2026
Same journal

Barriers to dengue vaccine uptake in international travelers: a mixed-methods study.

Expert review of vaccines·2026
Same journal

Recent advances for the pharmaceutical production of highly attenuated poxviruses as viral vector platforms.

Expert review of vaccines·2026
See all related articles

Economic evaluation of vaccination programs faces challenges in modeling, predicting uptake, and valuing benefits. Future developments aim for more sophisticated and accurate economic models for vaccines.

Area of Science:

  • Health economics
  • Vaccinology
  • Epidemiological modeling

Background:

  • Economic evaluation in healthcare, particularly for vaccination programs, has grown significantly since the 1980s.
  • Analyzing vaccine programs presents unique challenges for economic assessment.

Purpose of the Study:

  • To highlight key challenges in the economic evaluation of vaccination programs.
  • To identify areas for future development in vaccine economic modeling.

Main Methods:

  • Review of challenges in economic evaluation of vaccine programs.
  • Discussion of epidemiological modeling, uptake rate prediction, quality-adjusted survival gains, and intangible costs/benefits.
  • Analysis of marginal intervention costs and discount rate selection.

Related Experiment Videos

Main Results:

  • Key challenges include developing accurate epidemiological models, predicting vaccine uptake, incorporating quality-adjusted life years, and valuing intangible benefits.
  • Estimating marginal costs for multivalent vaccines and selecting appropriate discount rates for long-term cost-benefit analysis are particularly difficult.
  • Current methods require sophisticated approaches to accurately capture the full economic impact of vaccination.

Conclusions:

  • Economic evaluation of vaccines requires addressing complex methodological issues.
  • Advancements in the next five years are expected to yield more sophisticated and accurate models for assessing vaccination programs.
  • Improved economic models will enhance decision-making for healthcare resource allocation in immunization initiatives.